Aptamers Market
- Published Date: Aug-2021 |
- 180 Pages |
- Report ID: HE0296
Aptamers Market
The Aptamers Market is expected to grow from USD 2.54 billion in 2019 to USD 6.38 billion by 2026 at a CAGR of 14.1% from 2019 to 2026.
DNA and gene chips have increased much success in providing high throughput capabilities for comprehensive genome studies to boost disease knowledge and target them. This technology has developed as a valuable and promising solution across several aspects of disease management. These factors have been driving the market. Conventional means of gene analysis agree on the examination of relatively small amounts of genes at a time, which further underlines the uptake of DNA microarray technology. DNA microarray technology agrees on concurrent analysis of very large numbers of nucleic acid fragments in a single experiment. Gene chips are located on a glass substrate and have tiny cells that grip DNA inquiries. The cells are located in arrays, which makes it possible to carry a very large number of genetic tests on a given sample at a given time. They are used in pharmaceutical laboratories and in medical research to investigate the genes complicated in disease processes and to speed up the process of discovering new drugs. The global market is segregated on the basis of Product as Instrumentation and Consumables. Based on End-use the global market is segmented in Hospitals & Diagnostics Centers, Biotechnology & Pharmaceutical Companies, Others, and Academic & Government Research Institutes. Based on Application the global market is segmented in Genomics, Drug discovery, Agricultural biotechnology, Others, Cancer diagnosis and treatment, Gene expression, and Genotyping. Based on Type, the global market is segmented in RNA-Based Aptamers, XNA-Based Aptamers, and DNA-Based Aptamers.
The global Aptamers market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
CapitalBio Corporation, Greiner Bio-One International GmbH, Microarrays Inc, MYcroarray, Oxford Gene Technology, Am Biotechnologies, LLC, Thermo Fisher Scientific, Inc, Agilent Technologies, Illumina, Inc, Perkin Elmer, Inc, and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growth and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Aptamers market has been segmented as below:
By Product
- Instrumentation
- Consumables
By End-use
- Hospitals & Diagnostics Centers
- Biotechnology & Pharmaceutical Companies
- Others
- Academic & Government Research Institutes
By Application
- Genomics
- Drug discovery
- Agricultural biotechnology
- Others
- Cancer diagnosis and treatment
- Gene expression
- Genotyping
By Type
- RNA-Based Aptamers
- XNA-Based Aptamers
- DNA-Based Aptamers
By Region
- Europe
- North America
- Asia Pacific
- Rest of The World
By Company
- CapitalBio Corporation
- Greiner Bio One International GmbH
- Microarrays Inc
- MYcroarray
- Oxford Gene Technology
- Am Biotechnologies, LLC
- Thermo Fisher Scientific, Inc
- Agilent Technologies
- Illumina, Inc
- Perkin Elmer, Inc
The report covers the below scope:
- Global Aptamers market sizes from 2019 to 2026, along with CAGR for 2020-2026
- Market size comparison for 2020 vs 2026, with actual data for 2020, estimates for 2021 and forecast from 2021 to 2026
- Global market trends, covering a comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis of competition pattern, portfolio comparisons, development trends, and strategic management
- Comprehensive company profiles of the key industry players
The years considered for the study are as follows:
- Base year - 2019
- Estimated year - 2020
- Projected year - 2021
- Forecast period - 2021 to 2026
Report Scope:
The global Aptamers market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include CapitalBio Corporation, Greiner Bio-One International GmbH, Microarrays Inc, MYcroarray, Oxford Gene Technology, Am Biotechnologies, LLC, Thermo Fisher Scientific, Inc, Agilent Technologies, Illumina, Inc, Perkin Elmer, Inc, and others.
Why to Buy this Report:
- Gain detailed insights on the Aptamers industry trends
- Find a complete analysis of the market status
- Identify the market opportunities and growth segments
- Analyze competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Target Audience:
The report targeted the existing players in the industry is as follows:
- Market Manufacturers/Service Providers
- Market Wholesale/Traders
- Investment and Financial Institutions
Free and Paid Customization based on the requirement
Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Aptamers Market, By Product
5.1 Introduction
5.2 Instrumentation
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Consumables
5.3.1 Market Overview
5.3.2 Market Size and Forecast
- Aptamers Market, By End-use
6.1 Introduction
6.2 Hospitals & Diagnostics Centers
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Biotechnology & Pharmaceutical Companies
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Others
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Academic & Government Research Institutes
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- Aptamers Market, By Application
7.1 Introduction
7.2 Genomics
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Drug discovery
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Agricultural biotechnology
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Others
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Cancer diagnosis and treatment
7.6.1 Market Overview
7.6.2 Market Size and Forecast
7.7 Gene expression
7.7.1 Market Overview
7.7.2 Market Size and Forecast
7.8 Genotyping
7.8.1 Market Overview
7.8.2 Market Size and Forecast
- Aptamers Market, By Type
8.1 Introduction
8.2 RNA-Based Aptamers
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 XNA-Based Aptamers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 DNA-Based Aptamers
8.4.1 Market Overview
8.4.2 Market Size and Forecast
- Aptamers Market, By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Product
9.2.2 Europe Market, By End-use
9.2.3 Europe Market, By Application
9.2.4 Europe Market, By Type
9.3 North America
9.3.1 North America Market, By Product
9.3.2 North America Market, By End-use
9.3.3 North America Market, By Application
9.3.4 North America Market, By Type
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Product
9.4.2 Asia Pacific Market, By End-use
9.4.3 Asia Pacific Market, By Application
9.4.4 Asia Pacific Market, By Type
9.5 Rest of The World
9.5.1 Rest of The World Market, By Product
9.5.2 Rest of The World Market, By End-use
9.5.3 Rest of The World Market, By Application
9.5.4 Rest of The World Market, By Type
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
11.1 CapitalBio Corporation
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Greiner Bio One International GmbH
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Microarrays Inc
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 MYcroarray
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Oxford Gene Technology
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Am Biotechnologies, LLC
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Thermo Fisher Scientific, Inc
11.7.1 Company Overview
&